Considering individual chronic diseases, participants with cerebrovascular disease showed lower Aβ42/40 ratio and higher concentrations of NfL and GFAP, and those with heart diseases showed lower Aβ42/40 ratio and higher levels of p‐tau181, t‐tau, and NfL, compared with participants free from these diseases (Figure 4). This evidence concerns the gene NEFL and heart disorder.